Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.
2.

Anastrozole--a new generation in aromatase inhibition: clinical pharmacology.

Dowsett M, Lønning PE.

Oncology. 1997;54 Suppl 2:11-4. Review.

PMID:
9394854
3.

Pharmacological and clinical profile of anastrozole.

Lønning PE, Geisler J, Dowsett M.

Breast Cancer Res Treat. 1998;49 Suppl 1:S53-7; discussion S73-7. Review.

PMID:
9797018
4.

Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer.

Sanford M, Plosker GL.

Drugs. 2008;68(9):1319-40. Review.

PMID:
18547136
5.

[Development of a novel aromatase inhibitor, anastrozole (Arimidex)--its basic and clinical studies].

Tsukagoshi S.

Gan To Kagaku Ryoho. 2001 Apr;28(4):549-60. Review. Japanese.

PMID:
11329794
6.

ARIMIDEX: a new oral, once-a-day aromatase inhibitor.

Plourde PV, Dyroff M, Dowsett M, Demers L, Yates R, Webster A.

J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):175-9. Review.

PMID:
7626450
7.

Role of anastrozole in adjuvant therapy for postmenopausal patients.

Buzdar AU.

Semin Oncol. 2003 Oct;30(5 Suppl 16):21-9. Review.

PMID:
14613023
8.

Anastrozole (Arimidex)--an aromatase inhibitor for the adjuvant setting?

Buzdar AU.

Br J Cancer. 2001 Nov;85 Suppl 2:6-10. Review.

9.

Focus on anastrozole and breast cancer.

Mokbel K.

Curr Med Res Opin. 2003;19(8):683-8. Review.

PMID:
14687437
10.

Pharmacokinetics of third-generation aromatase inhibitors.

Lønning P, Pfister C, Martoni A, Zamagni C.

Semin Oncol. 2003 Aug;30(4 Suppl 14):23-32. Review.

PMID:
14513434
11.

Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer.

Köberle D, Thürlimann B.

Expert Rev Anticancer Ther. 2001 Aug;1(2):169-76. Review.

PMID:
12113022
12.

Anastrozole: a selective aromatase inhibitor for the treatment of breast cancer.

Higa GM, alKhouri N.

Am J Health Syst Pharm. 1998 Mar 1;55(5):445-52. Review.

PMID:
9522927
13.

Anastrozole: a new addition to the armamentarium against advanced breast cancer.

Buzdar AU.

Am J Clin Oncol. 1998 Apr;21(2):161-6. Review.

PMID:
9537204
14.

Drug and hormone interactions of aromatase inhibitors.

Dowsett M.

Endocr Relat Cancer. 1999 Jun;6(2):181-5. Review.

15.

The biology of steroid hormones and endocrine treatment of breast cancer.

Dowsett M, Folkerd E, Doody D, Haynes B.

Breast. 2005 Dec;14(6):452-7. Epub 2005 Sep 28. Review.

PMID:
16198110
16.

Refining the postmenopausal breast cancer treatment paradigm: the FACE trial.

Monnier A.

Expert Rev Anticancer Ther. 2006 Oct;6(10):1355-9. Review.

PMID:
17069521
17.

Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial.

Buzdar A.

Clin Breast Cancer. 2003 Apr;4 Suppl 1:S42-8. Review.

PMID:
12756078
18.

Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.

Geisler J.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):245-53. Review.

PMID:
14623518
19.

Clinical overview of anastrozole--a new selective oral aromatase inhibitor.

Jonat W.

Oncology. 1997;54 Suppl 2:15-8. Review.

PMID:
9394855
20.

Letrozole: a review of its use in postmenopausal women with breast cancer.

Simpson D, Curran MP, Perry CM.

Drugs. 2004;64(11):1213-30. Review.

PMID:
15161328

Supplemental Content

Support Center